ANGO vs EXC · rev $292.5M vs P/E 17, rev $23.03B
AngioDynamics Inc (ANGO) versus Exelon Corporation (EXC) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Exelon Corporation (EXC) is a utilities - regulated electric company listed on NASDAQ.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported EXC revenue for 2024-12-31 was $23.03B. Net income was $2.46B. Revenue was up 6.0% from 2023-12-31 to 2024-12-31. EXC currently screens at market cap $47.33B and trailing P/E 16.8.
ANGO currently screens at market cap $378.5M. EXC currently screens at market cap $47.33B and trailing P/E 16.8.
Not investment advice. Open the ANGO and EXC stock pages for the full models.
Not investment advice.